Novo Nordisk A/S : Novo Nordisk A/S - Share repurchase programme

April 17, 2012 08:01 ET | Source: Novo Nordisk A/S Novo Nordisk A/S

Attachments

Company Announcement no 24 2012

Company Announcement no 24 2012...

Recommended Reading

September 07, 2026 07:12 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 07 September 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Read More
September 07, 2026 06:00 ET | Source: Novo Nordisk A/S

Novo Nordisk STEP Young phase 3 data: 40.4% of children living with obesity achieved a BMI below the obesity threshold with semaglutide and lifestyle modification

STEP Young data show 40.4% of children treated with semaglutide and lifestyle modification were no longer classified as having obesity.
Read More